These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33775753)

  • 21. Development of Delivery Systems Enhances the Potency of Cell-Based HIV-1 Therapeutic Vaccine Candidates.
    Hadi A; Rastgoo A; Eskandarian M; Haghighipour N; Bolhassani A
    J Immunol Res; 2021; 2021():5538348. PubMed ID: 33997055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses.
    Climent N; Munier S; Piqué N; García F; Pavot V; Primard C; Casanova V; Gatell JM; Verrier B; Gallart T
    Vaccine; 2014 Oct; 32(47):6266-76. PubMed ID: 25240755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract.
    Ruane D; Do Y; Brane L; Garg A; Bozzacco L; Kraus T; Caskey M; Salazar A; Trumpheller C; Mehandru S
    Mucosal Immunol; 2016 Sep; 9(5):1340-52. PubMed ID: 26732678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines.
    Wilson CC; Olson WC; Tuting T; Rinaldo CR; Lotze MT; Storkus WJ
    J Immunol; 1999 Mar; 162(5):3070-8. PubMed ID: 10072560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different dendritic cells-based vaccine constructs influence HIV-1 antigen-specific immunological responses and cytokine generation in virion-exposed splenocytes.
    Milani A; Agi E; Hassan Pouriayevali M; Motamedi-Rad M; Motevalli F; Bolhassani A
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109406. PubMed ID: 36461600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of two HIV-1 multiepitope polypeptides for stimulation of immune responses in BALB/c mice.
    Kardani K; Hashemi A; Bolhassani A
    Mol Immunol; 2020 Mar; 119():106-122. PubMed ID: 32007753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of the immunogenicity of different recombinant Mengo viruses expressing HIV1 and SIV epitopes.
    Van der Ryst E; Nakasone T; Habel A; Venet A; Gomard E; Altmeyer R; Girard M; Borman AM
    Res Virol; 1998; 149(1):5-20. PubMed ID: 9561560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine.
    Singh RA; Wu L; Barry MA
    J Immunol; 2002 Jan; 168(1):379-91. PubMed ID: 11751984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endotoxin-minimized HIV-1 p24 fused to murine hsp70 activates dendritic cells, facilitates endocytosis and p24-specific Th1 response in mice.
    Krupka M; Zachova K; Cahlikova R; Vrbkova J; Novak Z; Sebela M; Weigl E; Raska M
    Immunol Lett; 2015 Jul; 166(1):36-44. PubMed ID: 26021827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine.
    Kim BJ; Kim BR; Kook YH; Kim BJ
    Front Immunol; 2018; 9():643. PubMed ID: 29636755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses.
    Gu R; Shampang A; Nashar T; Patil M; Fuller DH; Ramsingh AI
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of HIV-1 antigens in plants as potential subunit vaccines.
    Meyers A; Chakauya E; Shephard E; Tanzer FL; Maclean J; Lynch A; Williamson AL; Rybicki EP
    BMC Biotechnol; 2008 Jun; 8():53. PubMed ID: 18573204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
    Gómez CE; Nájera JL; Jiménez V; Bieler K; Wild J; Kostic L; Heidari S; Chen M; Frachette MJ; Pantaleo G; Wolf H; Liljeström P; Wagner R; Esteban M
    Vaccine; 2007 Mar; 25(11):1969-92. PubMed ID: 17224219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-utilization of a TLR5 agonist and nano-formulation of HIV-1 vaccine candidate leads to increased vaccine immunogenicity and decreased immunogenic dose: A preliminary study.
    Rostami H; Ebtekar M; Ardestani MS; Yazdi MH; Mahdavi M
    Immunol Lett; 2017 Jul; 187():19-26. PubMed ID: 28479111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of nasal HIV vaccination with adenoviral vector-based nanocomplexes using mucoadhesive and DC-targeting adjuvants.
    Jiang Y; Li M; Zhang Z; Gong T; Sun X
    Pharm Res; 2014 Oct; 31(10):2748-61. PubMed ID: 24792827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered ClearColi™-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidate.
    Sadeghi L; Bolhassani A; Mohit E; Baesi K; Aghasadeghi MR; Milani A; Agi E
    Microb Pathog; 2024 Aug; 193():106749. PubMed ID: 38879140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of HIV-1 Vif and Vpu accessory proteins for delivery of polyepitope constructs harboring Nef, Gp160 and P24 using various cell penetrating peptides.
    Kardani K; Hashemi A; Bolhassani A
    PLoS One; 2019; 14(10):e0223844. PubMed ID: 31671105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving the potency of DNA vaccine encoding HIV-1 Nef antigen using two endogenous adjuvants in mouse model.
    Jafarzade BS; Sadat SM; Yaghobi R; Bolhassani A
    Bratisl Lek Listy; 2017; 118(9):564-569. PubMed ID: 29061065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.
    Niu L; Termini JM; Kanagavelu SK; Gupta S; Rolland MM; Kulkarni V; Pavlakis GN; Felber BK; Mullins JI; Fischl MA; Stone GW
    Vaccine; 2011 Mar; 29(11):2110-9. PubMed ID: 21241732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.